U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 141

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr19:45855791-45855792
GRCh38:
Chr19:45352533-45352534
ERCC2D673fsTrichothiodystrophy 1, photosensitive, Xeroderma pigmentosum, group D, Cerebrooculofacioskeletal syndrome 2
Likely pathogenic
(Nov 29, 2022)
criteria provided, single submitter
2.
GRCh37:
Chr19:45855470-45855471
GRCh38:
Chr19:45352212-45352213
ERCC2H729fsXeroderma pigmentosum, group DLikely pathogenic
(Jan 13, 2023)
criteria provided, single submitter
3.
GRCh37:
Chr19:45860626
Chr19:45855507
GRCh38:
Chr19:45357368
Chr19:45352249
ERCC2, ERCC2L461V, A717GXeroderma pigmentosumPathogenic
(Jan 4, 2023)
criteria provided, single submitter
4.
GRCh37:
Chr19:45867342
GRCh38:
Chr19:45364084
ERCC2E260fs, E284fsXeroderma pigmentosum, group DPathogenic
(May 4, 2022)
criteria provided, single submitter
5.
GRCh37:
Chr19:45867239
GRCh38:
Chr19:45363981
ERCC2not provided, Xeroderma pigmentosum, group DConflicting interpretations of pathogenicity
(Sep 17, 2022)
criteria provided, conflicting interpretations
6.
GRCh37:
Chr19:45855573
GRCh38:
Chr19:45352315
ERCC2R695HTrichothiodystrophy 1, photosensitive, Cerebrooculofacioskeletal syndrome 2, Xeroderma pigmentosum, group D,
not provided, Xeroderma pigmentosum
Uncertain significance
(Jun 13, 2022)
criteria provided, multiple submitters, no conflicts
7.
GRCh37:
Chr19:45867333
GRCh38:
Chr19:45364075
ERCC2R263H, R287HTrichothiodystrophy 1, photosensitive, Cerebrooculofacioskeletal syndrome 2, Xeroderma pigmentosum, group D,
not provided
Uncertain significance
(Sep 1, 2021)
criteria provided, multiple submitters, no conflicts
8.
GRCh37:
Chr19:45873396
GRCh38:
Chr19:45370138
ERCC2A10T, A34TCerebrooculofacioskeletal syndrome 2, Trichothiodystrophy 1, photosensitive, Xeroderma pigmentosum, group D,
not provided
Uncertain significance
(Oct 5, 2022)
criteria provided, multiple submitters, no conflicts
9.
GRCh37:
Chr19:45855838
GRCh38:
Chr19:45352580
ERCC2R658GTrichothiodystrophy 1, photosensitive, Xeroderma pigmentosum, group DLikely pathogenic
(Jun 15, 2021)
criteria provided, single submitter
10.
GRCh37:
Chr19:45868096-45868099
GRCh38:
Chr19:45364838-45364841
ERCC2Xeroderma pigmentosum, group DPathogenic
(Jan 1, 1997)
no assertion criteria provided
11.
GRCh37:
Chr19:45868191
GRCh38:
Chr19:45364933
ERCC2E143Q, E167Qnot provided, Cerebrooculofacioskeletal syndrome 2, Xeroderma pigmentosum, group D,
Trichothiodystrophy 1, photosensitive
Uncertain significance
(Oct 13, 2022)
criteria provided, multiple submitters, no conflicts
12.
GRCh37:
Chr19:45873404
GRCh38:
Chr19:45370146
ERCC2T31M, T7MCerebrooculofacioskeletal syndrome 2, Trichothiodystrophy 1, photosensitive, Xeroderma pigmentosum, group D,
not provided
Uncertain significance
(Feb 2, 2022)
criteria provided, multiple submitters, no conflicts
13.
GRCh37:
Chr19:45858100
GRCh38:
Chr19:45354842
ERCC2R518QInborn genetic diseases, Xeroderma pigmentosum, group D, Trichothiodystrophy 1, photosensitive,
Cerebrooculofacioskeletal syndrome 2, not provided
Uncertain significance
(Aug 10, 2022)
criteria provided, multiple submitters, no conflicts
14.
GRCh37:
Chr19:45867588
GRCh38:
Chr19:45364330
ERCC2D216E, D240EInborn genetic diseases, not provided, Cerebrooculofacioskeletal syndrome 2,
Xeroderma pigmentosum, group D, Trichothiodystrophy 1, photosensitive
Uncertain significance
(Nov 5, 2022)
criteria provided, multiple submitters, no conflicts
15.
GRCh37:
Chr19:45855800
GRCh38:
Chr19:45352542
ERCC2Xeroderma pigmentosum, group DLikely pathogenic
(Jun 1, 2021)
criteria provided, single submitter
16.
GRCh37:
Chr19:45867241
GRCh38:
Chr19:45363983
ERCC2Xeroderma pigmentosum, group DUncertain significance
(Jul 17, 2019)
criteria provided, single submitter
17.
GRCh37:
Chr19:45855803-45855804
GRCh38:
Chr19:45352545-45352546
ERCC2K671fsnot provided, Xeroderma pigmentosum, group DPathogenic
(Mar 22, 2022)
criteria provided, multiple submitters, no conflicts
18.
GRCh37:
Chr19:45873464
GRCh38:
Chr19:45370206
ERCC2Y11Cnot provided, Xeroderma pigmentosum, group DUncertain significance
(Nov 4, 2021)
criteria provided, multiple submitters, no conflicts
19.
GRCh37:
Chr19:45873439
GRCh38:
Chr19:45370181
ERCC2not provided, Xeroderma pigmentosum, group D, Inborn genetic diseases
Conflicting interpretations of pathogenicity
(Mar 19, 2022)
criteria provided, conflicting interpretations
20.
GRCh37:
Chr19:45872255
GRCh38:
Chr19:45368997
ERCC2Xeroderma pigmentosum, group DUncertain significance
(Apr 27, 2017)
criteria provided, single submitter
21.
GRCh37:
Chr19:45872205
GRCh38:
Chr19:45368947
ERCC2V53M, V77MXeroderma pigmentosum, group D, Inborn genetic diseasesUncertain significance
(Dec 27, 2021)
criteria provided, multiple submitters, no conflicts
22.
GRCh37:
Chr19:45867141
GRCh38:
Chr19:45363883
ERCC2Xeroderma pigmentosum, group D, Inborn genetic diseasesConflicting interpretations of pathogenicity
(Nov 6, 2019)
criteria provided, conflicting interpretations
23.
GRCh37:
Chr19:45860874
GRCh38:
Chr19:45357616
ERCC2Xeroderma pigmentosum, group DUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
24.
GRCh37:
Chr19:45860770
GRCh38:
Chr19:45357512
ERCC2V447ITrichothiodystrophy 1, photosensitive, Xeroderma pigmentosum, group DConflicting interpretations of pathogenicity
(Jun 5, 2020)
criteria provided, conflicting interpretations
25.
GRCh37:
Chr19:45860760
GRCh38:
Chr19:45357502
ERCC2R450Hnot provided, Xeroderma pigmentosum, Xeroderma pigmentosum, group D
Uncertain significance
(Oct 17, 2022)
criteria provided, multiple submitters, no conflicts
26.
GRCh37:
Chr19:45855456
GRCh38:
Chr19:45352198
ERCC2not provided, Xeroderma pigmentosum, group DConflicting interpretations of pathogenicity
(Sep 13, 2022)
criteria provided, conflicting interpretations
27.
GRCh37:
Chr19:45871900
GRCh38:
Chr19:45368642
ERCC2not provided, Inborn genetic diseases, Xeroderma pigmentosum, group D
Conflicting interpretations of pathogenicity
(Jun 27, 2022)
criteria provided, conflicting interpretations
28.
GRCh37:
Chr19:45868163
GRCh38:
Chr19:45364905
ERCC2N152S, N176SXeroderma pigmentosum, group D, Inborn genetic diseasesUncertain significance
(Apr 2, 2022)
criteria provided, multiple submitters, no conflicts
29.
GRCh37:
Chr19:45858047
GRCh38:
Chr19:45354789
ERCC2V536MCerebrooculofacioskeletal syndrome 2, Xeroderma pigmentosum, group D, Trichothiodystrophy 1, photosensitive,
not provided, Xeroderma pigmentosum, Xeroderma pigmentosum, group D
Uncertain significance
(Oct 17, 2022)
criteria provided, multiple submitters, no conflicts
30.
GRCh37:
Chr19:45856533
GRCh38:
Chr19:45353275
ERCC2not provided, Inborn genetic diseases, Xeroderma pigmentosum, group D
Conflicting interpretations of pathogenicity
(Aug 19, 2022)
criteria provided, conflicting interpretations
31.
GRCh37:
Chr19:45854923
GRCh38:
Chr19:45351665
ERCC2not provided, Xeroderma pigmentosum, group D, Inborn genetic diseases
Conflicting interpretations of pathogenicity
(Apr 30, 2022)
criteria provided, conflicting interpretations
32.
GRCh37:
Chr19:45854892
GRCh38:
Chr19:45351634
ERCC2L760FXeroderma pigmentosum, group DUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
33.
GRCh37:
Chr19:45854819
GRCh38:
Chr19:45351561
ERCC2Xeroderma pigmentosum, group DUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
34.
GRCh37:
Chr19:45867793
GRCh38:
Chr19:45364535
ERCC2N179D, N203DXeroderma pigmentosum, group DUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
35.
GRCh37:
Chr19:45867569
GRCh38:
Chr19:45364311
ERCC2M247V, M223VXeroderma pigmentosum, group DUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
36.
GRCh37:
Chr19:45856398
GRCh38:
Chr19:45353140
ERCC2R592Cnot specified, Xeroderma pigmentosum, group DUncertain significance
(May 10, 2023)
criteria provided, multiple submitters, no conflicts
37.
GRCh37:
Chr19:45856371
GRCh38:
Chr19:45353113
ERCC2R601Wnot provided, Xeroderma pigmentosum, group D, not specified
Conflicting interpretations of pathogenicity
(Jul 27, 2022)
criteria provided, conflicting interpretations
38.
GRCh37:
Chr19:45856357
GRCh38:
Chr19:45353099
ERCC2not provided, Xeroderma pigmentosum, group D, Xeroderma pigmentosum,
Inborn genetic diseases
Conflicting interpretations of pathogenicity
(Sep 25, 2022)
criteria provided, conflicting interpretations
39.
GRCh37:
Chr19:45856074
GRCh38:
Chr19:45352816
ERCC2V611AXeroderma pigmentosum, group D, not provided, Trichothiodystrophy 1, photosensitive
Uncertain significance
(Nov 3, 2021)
criteria provided, multiple submitters, no conflicts
40.
GRCh37:
Chr19:45854817
GRCh38:
Chr19:45351559
ERCC2Xeroderma pigmentosum, group DUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
41.
GRCh37:
Chr19:45854809
GRCh38:
Chr19:45351551
ERCC2Xeroderma pigmentosum, group DUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
42.
GRCh37:
Chr19:45854750
GRCh38:
Chr19:45351492
ERCC2, KLC3Xeroderma pigmentosum, group DUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
43.
GRCh37:
Chr19:45854725
GRCh38:
Chr19:45351467
ERCC2, KLC3Xeroderma pigmentosum, group DUncertain significance
(Mar 30, 2018)
criteria provided, single submitter
44.
GRCh37:
Chr19:45854720
GRCh38:
Chr19:45351462
ERCC2, KLC3Xeroderma pigmentosum, group DUncertain significance
(Apr 27, 2017)
criteria provided, single submitter
45.
GRCh37:
Chr19:45867291
GRCh38:
Chr19:45364033
ERCC2T277M, T301MXeroderma pigmentosum, group DUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
46.
GRCh37:
Chr19:45867263
GRCh38:
Chr19:45364005
ERCC2Inborn genetic diseases, Xeroderma pigmentosum, group DConflicting interpretations of pathogenicity
(Mar 14, 2022)
criteria provided, conflicting interpretations
47.
GRCh37:
Chr19:45856039
GRCh38:
Chr19:45352781
ERCC2V623IXeroderma pigmentosum, group D, not provided, Xeroderma pigmentosum
Uncertain significance
(Aug 16, 2022)
criteria provided, multiple submitters, no conflicts
48.
GRCh37:
Chr19:45856015
GRCh38:
Chr19:45352757
ERCC2R631CXeroderma pigmentosum, group D, not providedUncertain significance
(Aug 11, 2022)
criteria provided, multiple submitters, no conflicts
49.
GRCh37:
Chr19:45854706
GRCh38:
Chr19:45351448
ERCC2, KLC3Xeroderma pigmentosum, group DUncertain significance
(Mar 30, 2018)
criteria provided, single submitter
50.
GRCh37:
Chr19:45854671
GRCh38:
Chr19:45351413
KLC3, ERCC2Xeroderma pigmentosum, group DLikely benign
(Jan 13, 2018)
criteria provided, single submitter
51.
GRCh37:
Chr19:45854663
GRCh38:
Chr19:45351405
ERCC2, KLC3Xeroderma pigmentosum, group DUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
52.
GRCh37:
Chr19:45873490
GRCh38:
Chr19:45370232
ERCC2K2NXeroderma pigmentosum, group D, not providedUncertain significance
(Sep 1, 2021)
criteria provided, multiple submitters, no conflicts
53.
GRCh37:
Chr19:45856061
GRCh38:
Chr19:45352803
ERCC2Xeroderma pigmentosum, group D, Inborn genetic diseases, not provided
Likely benign
(Dec 2, 2021)
criteria provided, multiple submitters, no conflicts
54.
GRCh37:
Chr19:45860792
GRCh38:
Chr19:45357534
ERCC2Cerebrooculofacioskeletal syndrome 2, Xeroderma pigmentosum, group D, Trichothiodystrophy 1, photosensitive,
Inborn genetic diseases, not provided
Likely benign
(Oct 4, 2022)
criteria provided, multiple submitters, no conflicts
55.
GRCh37:
Chr19:45860581
GRCh38:
Chr19:45357323
ERCC2V476IXeroderma pigmentosum, not provided, Xeroderma pigmentosum, group D
Conflicting interpretations of pathogenicity
(Oct 10, 2022)
criteria provided, conflicting interpretations
56.
GRCh37:
Chr19:45854983
GRCh38:
Chr19:45351725
ERCC2not provided, Trichothiodystrophy 1, photosensitive, Xeroderma pigmentosum,
Xeroderma pigmentosum, group D
Conflicting interpretations of pathogenicity
(Oct 20, 2022)
criteria provided, conflicting interpretations
57.
GRCh37:
Chr19:45856080
GRCh38:
Chr19:45352822
ERCC2not provided, Xeroderma pigmentosum, Xeroderma pigmentosum, group D
Benign/Likely benign
(Nov 2, 2022)
criteria provided, multiple submitters, no conflicts
58.
GRCh37:
Chr19:45868390
GRCh38:
Chr19:45365132
ERCC2Inborn genetic diseases, not provided, Xeroderma pigmentosum, group D
Benign/Likely benign
(Sep 7, 2022)
criteria provided, multiple submitters, no conflicts
59.
GRCh37:
Chr19:45872355
GRCh38:
Chr19:45369097
ERCC2Xeroderma pigmentosum, Inborn genetic diseases, not provided,
Xeroderma pigmentosum, group D
Conflicting interpretations of pathogenicity
(Aug 24, 2022)
criteria provided, conflicting interpretations
60.
GRCh37:
Chr19:45868138
GRCh38:
Chr19:45364880
ERCC2Inborn genetic diseases, not provided, Xeroderma pigmentosum, group D
Conflicting interpretations of pathogenicity
(Sep 27, 2022)
criteria provided, conflicting interpretations
61.
GRCh37:
Chr19:45856383
GRCh38:
Chr19:45353125
ERCC2Xeroderma pigmentosum, not provided, Xeroderma pigmentosum, group D,
Inborn genetic diseases
Conflicting interpretations of pathogenicity
(Sep 22, 2022)
criteria provided, conflicting interpretations
62.
GRCh37:
Chr19:45858021
GRCh38:
Chr19:45354763
ERCC2not provided, Cerebrooculofacioskeletal syndrome 2, Trichothiodystrophy 1, photosensitive,
Xeroderma pigmentosum, group D, Inborn genetic diseases, Xeroderma pigmentosum
Benign/Likely benign
(Oct 5, 2022)
criteria provided, multiple submitters, no conflicts
63.
GRCh37:
Chr19:45856040
GRCh38:
Chr19:45352782
ERCC2Inborn genetic diseases, not provided, Xeroderma pigmentosum,
Xeroderma pigmentosum, group D
Conflicting interpretations of pathogenicity
(Oct 17, 2022)
criteria provided, conflicting interpretations
64.
GRCh37:
Chr19:45860724
GRCh38:
Chr19:45357466
ERCC2not provided, Xeroderma pigmentosum, group DConflicting interpretations of pathogenicity
(Oct 27, 2022)
criteria provided, conflicting interpretations
65.
GRCh37:
Chr19:45858069
GRCh38:
Chr19:45354811
ERCC2Inborn genetic diseases, not provided, Cerebrooculofacioskeletal syndrome 2,
Xeroderma pigmentosum, group D, Trichothiodystrophy 1, photosensitive, Xeroderma pigmentosum
Likely benign
(Oct 17, 2022)
criteria provided, multiple submitters, no conflicts
66.
GRCh37:
Chr19:45924633-45924634
GRCh38:
Chr19:45421375-45421376
ERCC1S42fsXeroderma pigmentosum, group DUncertain significance
(Mar 2, 2018)
criteria provided, single submitter
67.
GRCh37:
Chr19:45923585
GRCh38:
Chr19:45420327
ERCC1L141fsXeroderma pigmentosum, group DUncertain significance
(Sep 6, 2017)
criteria provided, single submitter
68.
GRCh37:
Chr19:45868316-45868325
GRCh38:
Chr19:45365058-45365067
ERCC2S127fs, S151fsXeroderma pigmentosum, group DUncertain significance
(Jun 26, 2017)
criteria provided, single submitter
69.
GRCh37:
Chr19:45867379
GRCh38:
Chr19:45364121
ERCC2Xeroderma pigmentosum, group D, not providedPathogenic/Likely pathogenic
(Dec 3, 2021)
criteria provided, multiple submitters, no conflicts
70.
GRCh37:
Chr19:45872390
GRCh38:
Chr19:45369132
ERCC2E41*, E17*Xeroderma pigmentosum, group DPathogenic
(Feb 26, 2019)
no assertion criteria provided
71.
GRCh37:
Chr19:45871950
GRCh38:
Chr19:45368692
ERCC2E100*, E76*Xeroderma pigmentosum, group DPathogenic
(Feb 26, 2019)
no assertion criteria provided
72.
GRCh37:
Chr19:45872251
GRCh38:
Chr19:45368993
ERCC2Xeroderma pigmentosum, group DPathogenic
(Feb 26, 2019)
no assertion criteria provided
73.
GRCh37:
Chr19:45867799
GRCh38:
Chr19:45364541
ERCC2H201Y, H177Ynot provided, Xeroderma pigmentosum, Xeroderma pigmentosum, group D
Conflicting interpretations of pathogenicity
(Oct 17, 2022)
criteria provided, conflicting interpretations
74.
GRCh37:
Chr19:45868091-45868094
GRCh38:
Chr19:45364833-45364836
ERCC2Xeroderma pigmentosum, group D, not provided, Xeroderma pigmentosum,
Trichothiodystrophy 1, photosensitive
Pathogenic/Likely pathogenic
(Feb 20, 2023)
criteria provided, multiple submitters, no conflicts
75.
GRCh37:
Chr19:45873788
GRCh38:
Chr19:45370530
ERCC2Xeroderma pigmentosum, group DUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
76.
GRCh37:
Chr19:45872364
GRCh38:
Chr19:45369106
ERCC2Xeroderma pigmentosum, group DUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
77.
GRCh37:
Chr19:45872326
GRCh38:
Chr19:45369068
ERCC2Xeroderma pigmentosum, group D, not providedConflicting interpretations of pathogenicity
(Aug 9, 2023)
criteria provided, conflicting interpretations
78.
GRCh37:
Chr19:45871940
GRCh38:
Chr19:45368682
ERCC2P103L, P79Lnot provided, Xeroderma pigmentosum, group DUncertain significance
(May 4, 2022)
criteria provided, multiple submitters, no conflicts
79.
GRCh37:
Chr19:45868118
GRCh38:
Chr19:45364860
ERCC2P191L, P167LXeroderma pigmentosum, group DUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
80.
GRCh37:
Chr19:45867709
GRCh38:
Chr19:45364451
ERCC2V231M, V207Mnot provided, Xeroderma pigmentosum, group DUncertain significance
(Sep 1, 2022)
criteria provided, multiple submitters, no conflicts
81.
GRCh37:
Chr19:45867676
GRCh38:
Chr19:45364418
ERCC2not provided, Xeroderma pigmentosum, group DBenign/Likely benign
(Jul 7, 2023)
criteria provided, multiple submitters, no conflicts
82.
GRCh37:
Chr19:45867568
GRCh38:
Chr19:45364310
ERCC2M247T, M223Tnot provided, Xeroderma pigmentosum, group DUncertain significance
(Sep 27, 2022)
criteria provided, multiple submitters, no conflicts
83.
GRCh37:
Chr19:45867559
GRCh38:
Chr19:45364301
ERCC2N250T, N226TInborn genetic diseases, not provided, Xeroderma pigmentosum, group D
Uncertain significance
(Oct 4, 2022)
criteria provided, multiple submitters, no conflicts
84.
GRCh37:
Chr19:45867291
GRCh38:
Chr19:45364033
ERCC2T301K, T277KXeroderma pigmentosum, group DUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
85.
GRCh37:
Chr19:45867247
GRCh38:
Chr19:45363989
ERCC2Q316E, Q292Enot provided, Cerebrooculofacioskeletal syndrome 2, Xeroderma pigmentosum, group D,
Trichothiodystrophy 1, photosensitive, Xeroderma pigmentosum, group D
Uncertain significance
(Sep 7, 2022)
criteria provided, multiple submitters, no conflicts
86.
GRCh37:
Chr19:45867235
GRCh38:
Chr19:45363977
ERCC2not provided, Xeroderma pigmentosum, group DConflicting interpretations of pathogenicity
(Aug 23, 2022)
criteria provided, conflicting interpretations
87.
GRCh37:
Chr19:45867182
GRCh38:
Chr19:45363924
ERCC2Xeroderma pigmentosum, group DUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
88.
GRCh37:
Chr19:45867131
GRCh38:
Chr19:45363873
ERCC2not provided, Xeroderma pigmentosum, group D, Xeroderma pigmentosum,
Inborn genetic diseases
Conflicting interpretations of pathogenicity
(Apr 8, 2022)
criteria provided, conflicting interpretations
89.
GRCh37:
Chr19:45866997
GRCh38:
Chr19:45363739
ERCC2not provided, Xeroderma pigmentosum, group DUncertain significance
(Aug 9, 2022)
criteria provided, multiple submitters, no conflicts
90.
GRCh37:
Chr19:45864777
GRCh38:
Chr19:45361519
ERCC2Xeroderma pigmentosum, group DUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
91.
GRCh37:
Chr19:45860919
GRCh38:
Chr19:45357661
ERCC2P426SXeroderma pigmentosum, group D, Inborn genetic diseasesUncertain significance
(Oct 17, 2021)
criteria provided, multiple submitters, no conflicts
92.
GRCh37:
Chr19:45860746
GRCh38:
Chr19:45357488
ERCC2I455Vnot provided, Xeroderma pigmentosum, group D, Inborn genetic diseases
Uncertain significance
(Sep 27, 2022)
criteria provided, multiple submitters, no conflicts
93.
GRCh37:
Chr19:45860603
GRCh38:
Chr19:45357345
ERCC2Inborn genetic diseases, Xeroderma pigmentosum, group DConflicting interpretations of pathogenicity
(Nov 20, 2022)
criteria provided, conflicting interpretations
94.
GRCh37:
Chr19:45858009
GRCh38:
Chr19:45354751
ERCC2not provided, Xeroderma pigmentosum, group D, Inborn genetic diseases
Conflicting interpretations of pathogenicity
(Oct 22, 2022)
criteria provided, conflicting interpretations
95.
GRCh37:
Chr19:45858004
GRCh38:
Chr19:45354746
ERCC2A550VXeroderma pigmentosum, group DUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
96.
GRCh37:
Chr19:45856059
GRCh38:
Chr19:45352801
ERCC2R616PXeroderma pigmentosum, Inborn genetic diseases, not provided,
Xeroderma pigmentosum, group D, Xeroderma pigmentosum, group D, Trichothiodystrophy 1, photosensitive,
Cerebrooculofacioskeletal syndrome 2
Pathogenic
(Jul 18, 2023)
criteria provided, multiple submitters, no conflicts
97.
GRCh37:
Chr19:45855905
GRCh38:
Chr19:45352647
ERCC2Xeroderma pigmentosum, group D, not provided, Xeroderma pigmentosum,
Inborn genetic diseases
Conflicting interpretations of pathogenicity
(Oct 28, 2022)
criteria provided, conflicting interpretations
98.
GRCh37:
Chr19:45855848
GRCh38:
Chr19:45352590
ERCC2not provided, Xeroderma pigmentosum, Inborn genetic diseases,
Xeroderma pigmentosum, group D
Conflicting interpretations of pathogenicity
(Oct 5, 2022)
criteria provided, conflicting interpretations
99.
GRCh37:
Chr19:45855563
GRCh38:
Chr19:45352305
ERCC2Xeroderma pigmentosum, group DUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
100.
GRCh37:
Chr19:45855530
GRCh38:
Chr19:45352272
ERCC2not provided, Inborn genetic diseases, Xeroderma pigmentosum, group D
Conflicting interpretations of pathogenicity
(Jul 28, 2022)
criteria provided, conflicting interpretations
Format
Items per page
Sort by
Choose Destination